Research field (3):
Tumor diagnostics and therapeutics
, Gastroenterology
, Tumor biology
Research keywords (4):
Clinical Oncology
, Cancer Genome Profiling
, Cancer Stem Cell
, Cancer Chemotherapy
Research theme for competitive and other funds (3):
2022 - 2025 CDKN3 inhibitor as a new compound to overcome the resistance to cytotoxic chemotherapy
2019 - 2022 CDKN3 as a new target of anti-cancer treatment overcoming the resistance to cytotoxic chemotherapy
2016 - 2018 The mechanism of chemotherapy resistance in colon cancer stem cells and epithelial mesenchymal transition colon cancer cells
Papers (51):
Shogo Yamamura, Masashi Kanai, Yasuhide Takeuchi, Natsuko Okita, Tomohiro Kondo, Masahiro Yoshioka, Junichi Matsubara, Shigemi Matsumoto, Manabu Muto. Response to capmatinib in a patient with neuroendocrine carcinoma of the gallbladder origin harboring MET amplification. International cancer conference journal. 2024. 13. 2. 83-87
2009 - American Association for Cancer Research Scholar-in-Training Award
Show all
Association Membership(s) (9):
The Molecular Biology Society of Japan
, American Society of Clinical Oncology (ASCO)
, American Association for Cancer Research (AACR)
, 日本胃癌学会
, 日本癌治療学会
, 日本癌学会
, 日本臨床腫瘍学会
, 日本消化器病学会
, 日本内科学会